From November 5th to 10th, 2025, the 8th China International Import Expo (CIIE) will be held at the National Exhibition and Convention Center (Shanghai). To date, several leading medical device companies have confirmed their participation, including Johnson & Johnson.China, Medtronic, Philips, GE Healthcare, Siemens Healthineers, Boston Scientificetc. This article willTo bring you some of the latest medical device "black tech" products that relevant companies will showcase at this year's CIIE.

01

Johnson & Johnson

As a "full-time participant" of the CIIE, Johnson & Johnson focuses on two major business sectors: medical technology and innovative pharmaceuticals. This year, it will once again bring more than a hundred innovative products to the event as promised.

Among them,This year, Johnson & Johnson is introducing the CEREGLIDE™ 71 Distal Access Catheter for its Asian debut, a device that can be used as an access catheter for various neurovascular-related conditions.With its high precision, anti-kinking, and more durable performance, this product can reach up to the M1-M2 segments of the brain, rapidly establishing an auxiliary pathway and saving precious treatment time for stroke patients.

Boston Scientific was founded in 1979, with its global headquarters located in Massachusetts, USA. It currently offers more than 15,000 products that improve quality of life, serving over 140 countries and regions worldwide. Each year, it helps improve the lives of 37 million patients globally and is one of the medical device companies with the largest R&D investment.

The company has participated in the CIIE for seven consecutive sessions. At the eighth CIIE, Boston Scientific will present more than 80 innovative exhibits. Among them,Five new products showcased for the first time cover areas such as liver tumors, healthy weight management, atrial fibrillation ablation, carotid artery disease, and male stress urinary incontinence; 22 innovative "exhibit-to-product" items will also make a collective appearance, two of which will be exhibited for the first time in China after their nationwide launch.

Medtronic was founded in 1949, and its operational headquarters is located in the United States.The business portfolio covers more than 70 key disease areas of the human body, including cardiovascular, surgical and critical care, neuroscience, and diabetes businesses.

This year, Medtronic, with the theme of "Co-creating the Future of Medical Technology," showcased more than a hundred innovative achievements at the CIIE.InRhythm of Life, Central Universe, Future Surgery, Intelligent HealthcareFor the four major thematic areas, willConcentrated DisplayIntelligent, Minimally Invasive, and Platform-based Medical TechnologyThe development trend allows the industry to get up close with several groundbreaking "black technologies."

IncludingAsia-Pacific Premiere: Inceptiv Implantable Rechargeable Spinal Cord Neurostimulator, China Debut: CathWorks FFRangio System, Avalus Ultra Artificial Heart Valve, OmniaSecure Defibrillation Lead Implantable Defibrillation Electrode Leadetc.

Siemens Healthineers benefits from the spillover effect of the CIIE ("Exhibits become goods, goods become products"), with multiple globally leading and innovative exhibits being accelerated for approval, market entry, and implementation in China, and even achieving local production, thereby benefiting Chinese patients earlier.

This year,Siemens Healthineers will participate in the CIIE for the eighth consecutive year, and for the first time, it will exhibit jointly with Varian Medical. At that time, Siemens Healthineers will showcase more than 30 innovative products and solutions.Comprehensively showcase the most cutting-edge medical technology innovation achievements, as well as the company's latest breakthroughs in reshaping the diagnosis and treatment pathways for major diseases and leading the development of medical artificial intelligence.

Among them,At the 8th CIIE, Siemens Healthineers' ultra-fast spectral angiography system ARTIS icono ceiling Xpand will make its Asian debut.The deviceBased on Siemens AI technology, the system has achieved for the first timeDynaCT "One-Click Bone Removal" function reduces the originally time-consuming manual operation of about 2 minutes to be automatically completed within 15 seconds, increasing treatment efficiency by up to 8 times.

In addition,Siemens Healthineers will also introduce three new devices from the "Photon-counting CT family" for their Asia premiere., achieving a spatial resolution of up to 110 microns, reducing radiation dose by more than 90% compared to traditional CT, and supporting multi-material separation spectral imaging, which is expected to bring revolutionary breakthroughs.

AsParticipating for eight consecutive sessions"Perfect Attendance Student", AllGlobal medical technology company Olympus will present "New Era, New Vision" as the theme, fully showcasing its innovative achievements in technology research and development, localized production, minimally invasive diagnosis and treatment, department construction, and service training.

As a深耕者 in the medical industry, Olympus currently has the capability to treatMultifunctional Medical Device for Approximately 100 Diseases, can serveFields such as digestion, respiration, otorhinolaryngology, urology, and gynecology, provideFrom "Diagnosis" to "Treatment": Comprehensive Products and Solutions。At this year's CIIE, Olympus will make a significant release.Medical products in the field of internal medicine and surgery with "Made in China" innovation。

Gore Company (referred to as "Gore") is committed to providing various diagnostic and therapeutic solutions and medical devices for doctors and patients. Gore's medical products work in conjunction with body tissues and organs to enable less invasive surgeries, helping restore normal function.Currently, more than 40 million Gore Medical products have been implanted in patients worldwide.

Gore, participating in the CIIE for the first time this year, will introduce the EXCC (Expandable Custom Conformable Endovascular AAA Stent Graft System), aiming to lead the way into a new era of minimally invasive treatment for endovascular abdominal aortic aneurysms.EXCC can achieve durable sealing in shorter aneurysm necks, extending the anatomical indications for the proximal neck to a length of 10 mm and a maximum angulation of 90°, providing a safe and effective new treatment option for patients with "hostile necks" that are difficult to treat with traditional EVAR.